Skip to main content

Table 1 Demographic data, genetic or biochemical background and clinical phenotypes [23]

From: Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis

Patient Group

Age [years] range

Biochemical findings or variants found

Number of Patients

Clinical course

ACADM (NM_000016.5):

MCADD

(19 boys, 11 girls)

0ā€“17

c.985[Aā€‰>ā€‰G];[Aā€‰>ā€‰G] (Class 5; Class 5)

c.985Aā€‰>ā€‰G(;)c.199Ā Tā€‰>ā€‰C (Class 5; Class 3)

c.985Aā€‰>ā€‰G(;)c.362Cā€‰>ā€‰T (Class 5; Class 5)

c.985Aā€‰>ā€‰G(;)c.717Cā€‰>ā€‰G (Class 5; Class 5)

c.985Aā€‰>ā€‰G(;)c.476Gā€‰>ā€‰A (Class 5, Class 3)

mutation diagnosis was not performed, diagnosis based on metabolites

19

3

1

1

1

5

All were detected by selective newborn screening, no metabolic decompensation or clinical abnormalities based on the MCADD defect occurred

ACADVL (NM_000018.3):VLCADD

(2 boys, 4 girls)

0ā€“4

c.848[Tā€‰>ā€‰C];[Tā€‰>ā€‰C] (Class 4; Class 4)

2

no metabolic decompensation or clinical abnormalities based on the VLCADD defect occurred

c.848Ā Tā€‰>ā€‰C(;)c.1357Cā€‰>ā€‰T (Class 4; Class 5)

1

no metabolic decompensation or clinical abnormalities based on the VLCADD defect occurred

c.538Gā€‰>ā€‰A(;)c.1367Gā€‰>ā€‰A (Class 4; Class 4)

1

infection associated CK elevation occurred

c.779Cā€‰>ā€‰T(;)c.1700Gā€‰>ā€‰A (Class 4; Class 4)

1

infection associated CK elevation occurred

mutation diagnosis was not performed, diagnosis based on enzymatic analysis and metabolites

1

cardiomyopathy and recurrent infection associated rhabdomyolysis occurred in this patient

HADHA (NM_000182.4):

LCHADD

(5 boys, 1 girl)

1ā€“6

c.180ā€‰+ā€‰3Aā€‰>ā€‰G(;)c.1528Gā€‰>ā€‰C (Class 4; Class 5)

1

no metabolic decompensation or clinical abnormalities based on the LCHADD defect occurred

c.1528[Gā€‰>ā€‰C];[Gā€‰>ā€‰C] (Class 5, Class 5)

1

recurrent infection associated CK elevation occurred

c.914Ā Tā€‰>ā€‰A(;)c. 1528Gā€‰>ā€‰C (Class 3; Class 5)

3

One boy had no metabolic decompensation or clinical abnormalities based on the LCHADD defect, the younger brother had elevated CK levels and suffers from psychomotoric retardation. Another boy had no metabolic decompensation or clinical abnormalities based on the LCHAD defect

mutation diagnosis was not performed, diagnosis based on enzymatic analysis and metabolites

1

diagnosis due to severe metabolic decompensation accompanied by organ failure at the age of 8Ā months while suffering from gastrointestinal infection

CTD

(1 boy, 1 girl)

3ā€“5

mutation diagnosis was not performed, diagnosis based on enzymatic analysis and metabolites

2

no metabolic decompensation or clinical abnormalities based on the CT defect

ACADS (NM_ NM_000017.3):

SCADD (1 boy, 2 girls)

10ā€“13

c.625[Gā€‰>ā€‰A];[Gā€‰>ā€‰A] (Class 1; Class 1)

2

one patient was clinically unremarkable except for obesity, one suffered from psychiatric problems

mutation diagnosis was not performed, diagnosis based on metabolites

1

clinically unremarkable